AssuCryl Monoslow PDO Sutures - Suture, polydioxanone
Country: Australia
Language: English
Source: Department of Health (Therapeutic Goods Administration)
Public Assessment Report
(PAR)
16-11-2017
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Available from:
Med & Surgical Requisites Pty Ltd
Class:
Class III
Manufactured by:
Assut Medical SARL Av De Rochettaz 57 1009, Pully Switzerland
Therapeutic area:
16584 - Suture, polydioxanone
Therapeutic indications:
It is a monofilament synthetic absorbable suture composed of Poly-p-Dioxanon and available dyed and undyed. Absorption is complete after about 210 days. Intended for use in general soft tissue approximation and/or ligation and should not be used in cases where an extended wound support over a period of 6 weeks is desirable. AssuCryl MonoSlow can also be used in paediatric cardiovascular surgery, microsurgery and ophthalmologic surgery.
Authorization status:
A
Authorization date:
2009-06-19
